Migraine: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(→‎Potential treatments: extend, add ref)
(→‎Migraine attack treatments: order, ads refs, tidy)
Line 71: Line 71:


=== Migraine attack treatments ===
=== Migraine attack treatments ===
*[[:Category:Triptans|Triptans]] for moderate or severe migraine e.g. [[sumatriptan]] (Imitrex): 13 out of 14 newly diagnosed migraine subjects responded to sumatriptan in one [[Chronic fatigue syndrome|CFS]] patient cohort<ref name=":0" /> or [[zomitriptan]] (Zomig)<ref>{{Cite web|url=https://www.drugs.com/health-guide/migraine.html|title=Migraine Guide: Causes, Symptoms and Treatment Options|website=Drugs.com|language=en|access-date=2021-10-12}}</ref>
*General [[analgesic|pain medications]], including [[acetaminophen]] and [[Nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatories]] (NSAID), for mild to moderate migraines. Different types of medications are sometimes combined, for example acetaminophen and [[naproxen]].<ref name="Khan2021">{{Cite journal|last=Khan|first=Johra|last2=Asoom|first2=Lubna Ibrahim Al|last3=Sunni|first3=Ahmad Al|last4=Rafique|first4=Nazish|last5=Latif|first5=Rabia|last6=Saif|first6=Seham Al|last7=Almandil|first7=Noor B.|last8=Almohazey|first8=Dana|last9=AbdulAzeez|first9=Sayed|date=2021-07-01|title=Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine|url=https://www.sciencedirect.com/science/article/pii/S0753332221003425|journal=Biomedicine & Pharmacotherapy|language=en|volume=139|pages=111557|doi=10.1016/j.biopha.2021.111557|issn=0753-3322}}</ref>
*[[:Category:Triptans|Triptans]] for moderate or severe migraine e.g. [[sumatriptan]] (Imitrex): 13 out of 14 newly diagnosed migraine subjects responded to sumatriptan in one [[Chronic fatigue syndrome|CFS]] patient cohort<ref name=":0" /> or [[zomitriptan]] (Zomig)<ref name="drugscom">{{Cite web|url=https://www.drugs.com/health-guide/migraine.html|title=Migraine Guide: Causes, Symptoms and Treatment Options|website=Drugs.com|language=en|access-date=2021-10-12}}</ref>
*Small molecule [[:Category:CGRP antagonists|CGRP antagonists]], known as [[:Category:Gepants|gepants]], which are the newest group of migraine drugs<ref name=":1">{{Cite journal|last=Negro|first=Andrea|author-link=|last2=Martelletti|first2=Paolo|author-link2=|last3=|first3=|author-link3=|date=Jun 2019|title=Gepants for the treatment of migraine|url=https://pubmed.ncbi.nlm.nih.gov/31081399/|journal=Expert Opinion on Investigational Drugs|volume=28|issue=6|pages=555–567|doi=10.1080/13543784.2019.1618830|issn=1744-7658|pmc=|pmid=31081399|access-date=|quote=|via=}}</ref>
*Small molecule [[:Category:CGRP antagonists|CGRP antagonists]], known as [[:Category:Gepants|gepants]], which are the newest group of migraine drugs<ref name=":1">{{Cite journal|last=Negro|first=Andrea|author-link=|last2=Martelletti|first2=Paolo|author-link2=|last3=|first3=|author-link3=|date=Jun 2019|title=Gepants for the treatment of migraine|url=https://pubmed.ncbi.nlm.nih.gov/31081399/|journal=Expert Opinion on Investigational Drugs|volume=28|issue=6|pages=555–567|doi=10.1080/13543784.2019.1618830|issn=1744-7658|pmc=|pmid=31081399|access-date=|quote=|via=}}</ref>
*General [[analgesic|pain medications]], including [[acetaminophen]] and [[Nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatories]] (NSAID), for mild to moderate migraines. Different types of medications are sometimes combined, for example acetaminophen and [[naproxen]].<ref name=":2">{{Cite journal|last=Khan|first=Johra|last2=Asoom|first2=Lubna Ibrahim Al|last3=Sunni|first3=Ahmad Al|last4=Rafique|first4=Nazish|last5=Latif|first5=Rabia|last6=Saif|first6=Seham Al|last7=Almandil|first7=Noor B.|last8=Almohazey|first8=Dana|last9=AbdulAzeez|first9=Sayed|date=2021-07-01|title=Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine|url=https://www.sciencedirect.com/science/article/pii/S0753332221003425|journal=Biomedicine & Pharmacotherapy|language=en|volume=139|pages=111557|doi=10.1016/j.biopha.2021.111557|issn=0753-3322}}</ref>


=== Migraine prevention ===
=== Migraine prevention ===

Revision as of 00:17, October 14, 2021

Migraine headaches commonly occur in people with ME/CFS. In a 2011 study by Ravindran, et al, migraine headaches were found in 84%, and tension-type headaches in 81% of a cohort of CFS patients.[1] This compared to 5% and 45%, respectively, in a cohort of healthy controls.[1]

Symptoms[edit | edit source]

Migraine without aura is defined by the following diagnostic criteria outlined in The International Classification Of Headache Disorders, 3rd edition:

Migraine without aura diagnostic criteria[edit | edit source]

  1. At least five headache attacks that
  2. Last 4–72 hours without successful treatment
  3. Headaches have at least two of the following four characteristics:
    1. unilateral location;
    2. pulsating quality;
    3. moderate to severe pain intensity; and
    4. aggravation by or causing avoidance of routine physical activity.
  4. During the headaches at least one of the following:
    1. nausea and/or vomiting
    2. photophobia and phonophobia (avoidance of loud noises)
  5. Not better accounted for by another ICHD-3 diagnosis.
Migraines without aura may also be called common migraine' or hemicrania simplex.[2]

Migraine with aura diagnostic criteria[edit | edit source]

Visual, sensory and central nervous system symptom in beginning shortly before a migraine headache are known as an aura, although migraine with aura without migraine headaches are also recognized.
  1. At least two migraine attacks fulfilling criteria B and C
  2. One or more of the following fully reversible aura symptoms
    1. visual
    2. sensory
    3. speech and/or language
    4. motor
    5. brainstem
    6. retinal
  3. At least three of the following characteristics:
    1. at least one aura symptom spreads gradually over five minutes or longer
    2. two or more aura symptoms occur in succession
    3. each individual aura symptom lasts 5 to 60 minutes
    4. at least one aura symptom is unilateral (one sided)
    5. at least one aura symptom is positive
    6. the aura is accompanied, or followed within 60 minutes, by headache
  4. Not better accounted for by another ICHD-3 diagnosis.[2]

The recognized types of migraine with aura are:

  • Typical aura with headache
  • Typical aura without headache
  • Migraine with brainstem aura
  • Hemiplegic migraine, including familial hemiplegic migraine (FHM) type 1, type 2, type 3 and with other loci
  • Sporadic hemiplegic migraine (SHM)
  • Retinal migraine

Migraines without aura may also be called Classic or classical migraine, ophthalmic, hemiparaesthetic, hemiplegic or aphasic migraine, or complicated migraine.[2]

Chronic migraine[edit | edit source]

[2]

Abdominal migraine[edit | edit source]

[2]

Migraines in ME/CFS[edit | edit source]

Migraines is one of several illnesses or conditions experienced alongside of ME/CFS.[3]

The Canadian Consensus Criteria recognizes migraines in the possible neurological symptoms of ME/CFS.

Possible causes[edit | edit source]

Potential treatments[edit | edit source]

Migraine treatment consists of:

  • Abortive treatments, that aim to stop a migraine attack or reduce the symptoms
  • Prevention, which aims to reduce how often migraines occur and their intensity

Migraine attack treatments[edit | edit source]

Migraine prevention[edit | edit source]

Notable studies[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 1.3 Ravindran, Murugan K; Zheng, Yin; Timbol, Christian; Merck, Samantha J; Baraniuk, James N (March 5, 2011). "Migraine headaches in Chronic Fatigue Syndrome (CFS): Comparison of two prospective cross-sectional studies". BMC Neurology. 11 (1). doi:10.1186/1471-2377-11-30. ISSN 1471-2377. PMID 21375763.
  2. 2.0 2.1 2.2 2.3 2.4 Headache Classification Committee of the International Headache Society (2018). "The International Classification of Headache Disorders". Cephalalgia (3rd ed.). 38 (1): 1–211. doi:10.1177/0333102417738202. ISSN 0333-1024.
  3. "Overlapping Conditions – American ME and CFS Society". ammes.org. Retrieved August 12, 2018.
  4. Khan, Johra; Asoom, Lubna Ibrahim Al; Sunni, Ahmad Al; Rafique, Nazish; Latif, Rabia; Saif, Seham Al; Almandil, Noor B.; Almohazey, Dana; AbdulAzeez, Sayed (July 1, 2021). "Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine". Biomedicine & Pharmacotherapy. 139: 111557. doi:10.1016/j.biopha.2021.111557. ISSN 0753-3322.
  5. "Migraine Guide: Causes, Symptoms and Treatment Options". Drugs.com. Retrieved October 12, 2021.
  6. 6.0 6.1 6.2 Negro, Andrea; Martelletti, Paolo (June 2019). "Gepants for the treatment of migraine". Expert Opinion on Investigational Drugs. 28 (6): 555–567. doi:10.1080/13543784.2019.1618830. ISSN 1744-7658. PMID 31081399.
  7. Cite error: Invalid <ref> tag; no text was provided for refs named :2
  8. "Migraine - Prevention". National Health Service. October 23, 2017. Retrieved October 12, 2021.
  9. Cascio Rizzo, Angelo; Paolucci, Matteo; Altavilla, Riccardo; Brunelli, Nicoletta; Assenza, Federica; Altamura, Claudia; Vernieri, Fabrizio (2017). "Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation". Frontiers in Neurology. 8. doi:10.3389/fneur.2017.00624. ISSN 1664-2295. PMC 5711775. PMID 29230190.
  10. Rayhan, Rakib U.; Ravindran, Murugan K.; Baraniuk, James N. (2013). "Migraine in gulf war illness and chronic fatigue syndrome: prevalence, potential mechanisms, and evaluation". Frontiers in Physiology. 4: 181. doi:10.3389/fphys.2013.00181. ISSN 1664-042X. PMID 23898301.
  11. Gonzalez, Antonio; Hyde, Embriette; Sangwan, Naseer; Gilbert, Jack A.; Virre, Erik; Knight, Rob (October 18, 2016). "Migraines Are Correlated with Higher Levels of Nitrate-, Nitrite-, and Nitric Oxide-Reducing Oral Microbes in the American Gut Project Cohort" (PDF). American Society for Microbiology. 1 (5).
  12. Devlin, Hannah (October 18, 2016). "Migraines could be caused by gut bacteria, study suggests". the Guardian. Retrieved August 11, 2018.
  13. Johnson, Cort (May 19, 2018). "The Migraine Drug Explosion Begins: Could Fibromyalgia and ME/CFS Benefit? - Health Rising". Health Rising. Retrieved August 11, 2018.